Buy Crypto Markets Spot FuturesGOLD Earn Event Centre

Quantum Biopharma Ltd (QNTM)

NASDAQ

$3.08

$+0.85

(+37.95%)

Quantum Biopharma Ltd (QNTM) Live Price Chart

Page last updated: 2026-03-23 20:43:00

Key Market Data

Market Cap	$11.74M
Open	$2.21
High	$38.25
Low	$2.07
Previous Close	$2.24
Price Change	$+0.85
Percentage Change	+37.95%
Volume	1M

Quantum Biopharma Ltd (QNTM) Stock Price Today

Quantum Biopharma Ltd (QNTM) is currently trading at $3.08 as of 2026-03-23 20:43:00, reflecting a +37.95% move ($+0.85) from the previous close.

In the short term, the stock has returned -13.08% over the past four weeks. Over the last 12 months, Quantum Biopharma Ltd has recorded a -44.56% price change, indicating a weak performance relative to the broader market.

Quantum Biopharma Ltd (QNTM) 7-Day Stock Price Changes

Over the past seven days, Quantum Biopharma Ltd has traded within a short-term range shaped by market sentiment in the sector. During this period, the stock moved from its previous closing price of $2.41 to the latest recorded price of $3.08, reflecting an intraday change of +37.95%. Daily movements highlight shifts in trading volume (1,350,673), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, QNTM has delivered a -13.08% return over the past month and a -44.56% change in the last 12 months, indicating a weak trend relative to its broader sector peers.

How to Buy Quantum Biopharma Ltd (QNTM)

You can buy and trade QNTM on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for QNTM and Execute Your Trade

Open the trading page, enter QNTM in the search bar, select the amount of QNTM you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is Quantum Biopharma Ltd (QNTM)?

Quantum BioPharma Ltd is a biopharmaceutical company dedicated to building a portfolio of inventive assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, it is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, which represents loans secured by residential or commercial property.

Quantum Biopharma Ltd Information

Industry	--
Employees	7
Sector	--
Company Website	https://www.quantumbiopharma.com

Frequently Asked Questions (FAQ)

1.What is the current share price of Quantum Biopharma Ltd?

The latest trading price for Quantum Biopharma Ltd (Common Stock) is $ 3.08, compared with a previous closing price of $ 2.24. That means the stock has moved +37.95% so far today. Intraday price updates and recent trading activity for QNTM can be tracked on the live chart and quote section on this page.

2.Is Quantum Biopharma Ltd stock going up or down?

Looking at recent performances, QNTM has returned -13.08% over the past month, -81.97% over the last six months and -44.56% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe weak price momentum for Quantum Biopharma Ltd stock, but keep in mind that past returns do not guarantee future results.

3.Where does QNTM currently sit relative to its 52-week high and low?

In the most recent 52-week period, Quantum Biopharma Ltd has traded between a low of $ 2.07 and a high of $ 38.25. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether QNTM is currently nearer the top or the bottom of its one-year trading band.

4.How is Quantum Biopharma Ltd classified by sector and industry?

Quantum Biopharma Ltd is classified in the -- sector. In practice, this means Quantum Biopharma Ltd is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing QNTM’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the -- sector could influence Quantum Biopharma Ltd’s performance.

5.Where is Quantum Biopharma Ltd listed and how large is it by market value?

Quantum Biopharma Ltd is listed on the NASDAQ stock exchange in United States. Based on a market capitalisation of $ 11.74M, the company is classified as a Small-cap stock. Market cap gives a quick sense of Quantum Biopharma Ltd's size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does QNTM's EPS tell investors about its profitability?

Trailing-twelve-month EPS of -- summarises how much profit Quantum Biopharma Ltd has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track Quantum Biopharma Ltd's financial performance over time?

To follow Quantum Biopharma Ltd's financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how QNTM is performing and how the market is responding.

8.When is Quantum Biopharma Ltd expected to report earnings?

Quantum Biopharma Ltd's next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for QNTM, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in Quantum Biopharma Ltd's earnings reports?

Quantum Biopharma Ltd's earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether QNTM is meeting, beating or missing expectations.

10.How can I stay informed about Quantum Biopharma Ltd's results and guidance?

You can stay up to date on Quantum Biopharma Ltd by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for QNTM on this page helps you see how new information is being reflected in the stock.

11.Does Quantum Biopharma Ltd pay a regular cash dividend to its shareholders?

Quantum Biopharma Ltd Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of -- at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor QNTM's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for QNTM?

Based on the latest earnings data, QNTM has a dividend yield of -- and a dividend payout ratio of --. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Quantum Biopharma Ltd is an attractive income stock. The dividend payout ratio measures what percentage of earnings Quantum Biopharma Ltd distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is Quantum Biopharma Ltd?

Quantum Biopharma Ltd is a publicly traded company in the -- industry within the -- sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is QNTM valued in terms of P/E ratio and EPS?

Quantum Biopharma Ltd currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of --. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Quantum Biopharma Ltd's earnings. Comparing QNTM's P/E and EPS to those of other -- companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as Quantum Biopharma Ltd

The Walt Disney Company

DIS

Largest Market Cap

See US stocks with the highest market capitalisation

Most Actively Traded

Discover today's most actively traded US stocks

Duke Energy Corporation

DUK

General Motors Company

Nike, Inc.

NKE

Omega Healthcare Investors Inc.

OHI

Occidental Petroleum Corporation

OXY

Top Gainers

Browse today's leading gainers in the US stock market

Actelis Networks, Inc.

ASNS

bioAffinity Technologies, Inc.

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalisation

BTC

ETH

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

QNTM-to-USD Calculator

Amount

QNTM

USD

1 QNTM = 3.077 USD